Currently out of the existing stock ratings of Andrew D'silva, 56 are a BUY (93.33%), 4 are a HOLD (6.67%).

Andrew D'silva

Work Performance Price Targets & Ratings Chart

Analyst Andrew D'silva, currently employed carries an average stock price target met ratio of 51.2% that have a potential upside of 55.29% achieved within 189 days.

Andrew D'silva’s has documented 126 price targets and ratings displayed on 13 stocks. The coverage was on Healthcare, Industrials sectors.

Most recent stock forecast was given on OTRK, Ontrak at 20-Aug-2021.

Wall Street Analyst Andrew D'silva

Analyst best performing recommendations are on CYRX (CRYOPORT).
The best stock recommendation documented was for CYRX (CRYOPORT) at 8/24/2020. The price target of $45 was fulfilled within 2 days with a profit of $8.32 (22.68%) receiving and performance score of 113.41.

Average potential price target upside

ADMP Adamis Pharma CLPT Clearpoint Neuro CRMD CorMedix CTSO Cytosorbents Crp CYRX Cryoport HROW Harrow Health IIN IntriCon INFI Infinity Pharmaceuticals LFMD LifeMD MPLN MultiPlan OPRX OPTIMIZERx Corp OTRK Ontrak VRAY ViewRay

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

4 years 6 months 4 days ago
(13-May-2020)

0/2 (0%)

$7.2 (167.00%)

Hold

4 years 11 months 22 days ago
(26-Nov-2019)

0/1 (0%)

$1.7 (32.08%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Andrew D'silva?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?